Last reviewed · How we verify
Clinical Study of Anlotinib in Maintenance Treatment of Advanced NSCLC (CSOAIMTOAN)
Based on the need of clinical practice of maintenance therapy for advanced NSCLC and the reliable data of third-line treatment for non-small cell lung cancer, the investigators designed a clinical study of antinil hydrochloride versus pemetrexed in maintenance therapy for advanced NSCLC to prospectively evaluate the efficacy of antinil hydrochloride in maintenance therapy for advanced NSCLC. Value, to provide a scientific basis for prolonging the survival time of patients with advanced NSCLC, improving the quality of life of patients in the course of treatment, and optimizing treatment strategies to a greater extent.
Details
| Lead sponsor | The First Affiliated Hospital with Nanjing Medical University |
|---|---|
| Phase | NA |
| Status | UNKNOWN |
| Enrolment | 83 |
| Start date | Sat Jun 15 2019 00:00:00 GMT+0000 (Coordinated Universal Time) |
| Completion | Thu Dec 31 2020 00:00:00 GMT+0000 (Coordinated Universal Time) |
Conditions
- Nonsmall Cell Lung Cancer
Interventions
- Anlotinib
Countries
China